Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: Authorities have managed to mitigate the spread of the virus and the COVID-19 respiratory disease it causes among Singapore’s citizens by rigorous contact tracing and surveillance, earning praise from the World Health Organization. The Ministry of Health reported just 14 cases among Singaporeans and permanent residents on Saturday. But the disease is spreading rapidly within the large migrant worker community, highlighting what rights groups say is a weak link in containment efforts. Authorities have ramped up testing for the disease in the dormitories. Saturday’s new cases takes the total in the city-state, which is under a partial lockdown, to 5,992. It has reported 11 deaths from the disease.
Example Output: Singapore reports 942 new COVID-19 cases in record daily jump.

Example Input: The committee is also seeking the indictment of Vale and dam stability auditor TÜV SÜD for environmental damages and corporate responsibility for actions of their employees in the late-January disaster that killed nearly 250 people. The 400-page report recommended that a total of 15 individuals, including the two executives, be indicted for murder, wrongful bodily injury, environmental damages and pollution. Fabio Schvartsman stepped down as Vale’s CEO under pressure from prosecutors in March. Luciano Siani, also targeted by the committee, continues to serve as CFO. The committee’s initial report recommended manslaughter charges but at a hearing it approved an amendment to upgrade the charges to murder and add a 15th individual to its list for recommended indictments. Vale, a formerly state-owned Brazilian “national champion” which is a leading exporter and employer, said it “respectfully disagrees” with the indictment recommendations. A “forensic, technical and scientific conclusion about the causes of the dam burst” should be arrived at before holding certain people responsible, the company asserted in a statement. TÜV SÜD said it was cooperating in full but declined to comment further, citing ongoing investigations. Vale shares, which early in the session touched their highest since before the Brumadinho disaster, closed down 4.2%. The nonbinding recommendations could influence prosecutors in their ongoing probe of Vale and its executives for negligence regarding the disaster. “Vale’s tragedy is a series of tragedies,” the committee said in its report. “The immeasurable human loss; the countless dead animals; the environment destroyed for years, perhaps decades; the dreams and heritage of a lifetime buried by the carelessness, neglect, greed, usury, irresponsibility, indifference and sloppiness of a company that used to be a role model.”  Brazil must take action to ensure that “never again” will such a disaster occur, it said, recommending three laws that would require congressional approval. One would outlaw all tailings dams for mining and industrial waste. That would go far beyond a ban instituted in February on the specific type of “upstream” dam that ruptured. It would allow for 10 years to decommission the hundreds of existing tailings dams around the country, a costly move for miners. A separate bill would hike taxes calculated on mineral production, with a tax of up to 40% on more profitable or larger scale mines. The investment banking unit of Brazil’s Bradesco said such a tax is unlikely to be implemented given that comparable taxes in Australia and Mexico are up to 7.5%. But the bank said the rate is likely to rise for Brazilian miners from the current 3.5%. A third proposed law would expand the list of environmental crimes. Barclays analyst Amos Fletcher said he doubted that Congress would follow through on shutting down all types of tailings dams, a move that would halt a significant amount of mineral production, which Brazil counts on for a large portion of its GDP, he said. The recommendations may be depressing Vale’s stock price more than the indictments because of worries that such changes “would lead to more supply being squeezed,” he said. Vale’s tailings dam ruptured in the city of Brumadinho in the mining state of Minas Gerais in late January, releasing a torrent of mud that buried hundreds of people, including a cafeteria full of workers at lunchtime. In the following months, investigators and regulators pointed toward a risky “upstream” style of dam construction, improper maintenance and negligence. TÜV SÜD certified the dam as stable in 2018 despite pointing out concerns about drainage and monitoring systems. Vale has argued that it followed all the required safety measures. While authorities have yet to conclude the cause of the rupture, a Minas Gerais state official and other experts suspect liquefaction, in which solid materials such as sand lose strength and become more like liquid. That was the same cause of a 2015 rupture of another upstream Vale dam that killed 19.
Example Output: Brazil Senate panel says Vale CFO, ex-CEO should be indicted for murder.

Example Input: Although the release doesn’t give actual costs of warfarin versus some of the newer drugs, or factor in the cost of the usual monthly blood testing required of those taking the drug, it does note the cost of the gene testing used for the study, and that the $200 price tag is now less than a month’s prescription of one of the newer anti-coagulants on the market. The release gives results in both actual numbers of patients and the percentage of reduction of adverse events in those given the genetic test and a comparison group. Although it does so in general terms, the release covers the essentials: the risk of using blood thinners like warfarin and the risks of not using them. The release offers a good description of the design of the study. It was randomized and enrolled more than 1,600 older patients at high risk of blood clots following surgeries. The release explains that one group received warfarin dosing based on standard factors (age, height and weight) and the second group was dosed using these clinical factors plus their genetic variants. The release also offers a detailed breakdown on how many fewer side effects occurred among patients had genetic testing completed compared to those who didn’t. No mongering here. Nicely done and quite complete. Although the release briefly mentions the availability of a “newer anticoagulant,” it should have included a sentence or two about these newer injectable drugs and their overall risks and benefits in comparison to warfarin. It would also have been helpful to tell readers whether the genetic testing that appears to play a role in safer warfarin dosing would have clinical relevance for informing the use of the new blood thinners as well. The fact is that genetic testing is irrelevant for the newer anti-coagulants because they operate in a completely different manner. But all the blood thinners — old and new — carry the same risk of bleeding. The problem with warfarin is the variability in blood levels which requires frequent monitoring, hence the genetic tests to guide dosing. The careful reader will get it: testing for these genetic variants is still an experimental practice for the most part, and further testing of how the mutations affect warfarin is needed. But the release could have been more explicit in saying that no one is yet recommending genetic testing for millions of warfarin users. While the genetic tests are “available” in the sense that anyone can order them for the most part, they are not routinely used clinically and probably wouldn’t be covered by insurance so in that sense they are not widely available to most people. The release describes how the genetic test used in the new study differs from previous similar studies. Overall the language is careful and contextual. The headline should have been toned back a bit to note that this is early research and more study is needed before concluding that “Genetic testing helps set safe dose of common blood thinner,” as the headline now states.
Example Output:
Genetic testing helps set safe dose of common blood thinner